中文 | English
Return
Total: 34 , 1/4
Show Home Prev Next End page: GO
Author:( LIU Xingchen)

1.Study on relationship between changes of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery ischemia

Jing ZENG ; Xingchen LIU ; Xiaoyan YANG ; Benguo WANG

Chongqing Medicine 2014;(20):2582-2583,2586

2.Studies on Preparation and Physicochemical Properties of Recombined Human Interferon-? Microspheres

Fenglan SONG ; Fan YANG ; Yiqun YANG ; Xingchen LIU

China Pharmacy 2001;0(10):-

3.Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy

Dongdong XU ; Xingchen LI ; Haiyan XU ; Hui LI ; Yuhua LIU

Basic & Clinical Medicine 2017;37(3):330-334

4.Analysis on early results of using osteochondral autografts harvested from medial femoral condyle of the ipsilateral knee for the treatment of osteochondral lesion of the talus

Xingchen LI ; Xiangyang XU ; Chonglin YANG ; Jinhao LIU ; Yuan ZHU ; Bibo WANG ; Wengtao GE

Chinese Journal of Orthopaedics 2013;(4):348-353

5.Evaluation of midfoot function after subtalar arthrodesis

Chonglin YANG ; Xiangyang XU ; Xingchen LI ; Jinhao LIU ; Yuan ZHU ; Baofu WEI

Chinese Journal of Orthopaedics 2014;34(4):431-435

6.Preparation conditions of erythromycin gelatin microspheres

Tao LI ; Fan YANG ; Shaona DIAN ; Shanguang WU ; Ying CHEN ; Xingchen LIU ; Yingmei FU

Chinese Journal of Tissue Engineering Research 2008;12(41):8179-8182

7.Preparation and performance evaluation of a novel detrgent-enzymatic tissue-engineered tracheal matrix in rabbits

Fei SUN ; Shu PAN ; Hongcan SHI ; Fangbiao ZHANG ; Weidong ZHANG ; Gang YE ; Xingchen LIU

Chinese Journal of Thoracic and Cardiovascular Surgery 2014;30(1):38-41,55

8.Effect of Tibetan medicine zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2.

Xiangyang LI ; Yongnian LIU ; Yongping LI ; Junbo ZHU ; Xingchen YAO ; Yongfang LI ; Mei YANG ; Ming YUAN ; Xueru FAN ; Yuemiao YIN

Acta Pharmaceutica Sinica 2014;49(2):267-72

9.Expression of Toll like receptor in pancreatic cancer cells

Xingchen HU ; Dejun LIU ; Wenting LIU

Chinese Journal of Hepatobiliary Surgery 2023;29(4):285-291

10.Application of epidermal growth factor receptor tyrosine kinase inhibitor as the first-line therapy in patients with advanced non-small cell lung cancer.

Yang XU ; Liangan CHEN ; Qing TIAN ; Zhen YANG ; Wei ZHAO ; Ping WANG ; Xingchen LIU ; Chunsun LI

Chinese Journal of Lung Cancer 2010;13(1):48-53

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 34 , 1/4 Show Home Prev Next End page: GO